Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity

Abstract Introduction Increased visceral adipose tissue (VAT) has been shown to be associated with the development of insulin resistance, type 2 diabetes, stroke, and ischemic heart disease. It remains unknown whether fat distribution impacts on coagulation markers and/or the risk of ve...

Full description

Bibliographic Details
Main Authors: P. B. Chitongo, L. N. Roberts, L. Yang, R. K. Patel, R. Lyall, R. Luxton, S. J. B. Aylwin, R. Arya
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2017-07-01
Series:TH Open
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608942
_version_ 1819067912825077760
author P. B. Chitongo
L. N. Roberts
L. Yang
R. K. Patel
R. Lyall
R. Luxton
S. J. B. Aylwin
R. Arya
author_facet P. B. Chitongo
L. N. Roberts
L. Yang
R. K. Patel
R. Lyall
R. Luxton
S. J. B. Aylwin
R. Arya
author_sort P. B. Chitongo
collection DOAJ
description Abstract Introduction Increased visceral adipose tissue (VAT) has been shown to be associated with the development of insulin resistance, type 2 diabetes, stroke, and ischemic heart disease. It remains unknown whether fat distribution impacts on coagulation markers and/or the risk of venous thrombosis. This study evaluates markers of hypercoagulability in class III obesity (body mass index [BMI] >40 kg/m2) compared with nonobese controls. We further investigated whether hypercoagulability was influenced by VAT, metabolic syndrome, and metabolic markers, including adiponectin. Patients and Methods Ninety patients were recruited from the obesity clinic at King's College Hospital from November 2009 to December 2011. The inclusion criteria were class III obesity (BMI ≥40 kg/m2) and age 18 to 65 years. A control group (healthy ambulatory participants, with a BMI < 30 kg/m2) was recruited from volunteers responding to advertisement. Abdominal VAT and subcutaneous adipose tissue surface areas were determined by evaluation of a single-slice CT at spinal vertebra L4. Results Thrombin generation revealed a significantly increased peak and endogenous thrombin potential in patients compared with controls. Lag time and time to peak (ttP) were also significantly prolonged in patients. VAT was found to have the strongest association with thrombin generation parameters: lag time (β = 0.378; p < 0.001), peak thrombin (0.378; p = 0.04), and ttP (β = 0.373; p = 0.001). BMI was found to be a predictor for lag time only (β = 0.313; p = 0.003). SAT was not associated with any of the thrombin generation parameters (data not shown). VAT was found to be an independent determinant of peak thrombin, lag time, and ttP. The study suggests not only fat mass but also fat distribution, particularly visceral adiposity, mediates hypercoagulability in obesity.
first_indexed 2024-12-21T16:25:48Z
format Article
id doaj.art-2a1a7ffd775a4f26bc2c034fcfd261bf
institution Directory Open Access Journal
issn 2512-9465
2512-9465
language English
last_indexed 2024-12-21T16:25:48Z
publishDate 2017-07-01
publisher Georg Thieme Verlag KG
record_format Article
series TH Open
spelling doaj.art-2a1a7ffd775a4f26bc2c034fcfd261bf2022-12-21T18:57:28ZengGeorg Thieme Verlag KGTH Open2512-94652512-94652017-07-010102e146e15410.1055/s-0037-1608942Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid ObesityP. B. Chitongo0L. N. Roberts1L. Yang2R. K. Patel3R. Lyall4R. Luxton5S. J. B. Aylwin6R. Arya7Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, London, United KingdomDepartment of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, London, United KingdomDepartment of Endocrinology, King's College Hospital, London, United KingdomDepartment of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, London, United KingdomDepartment of Respiratory Medicine, Kings College Hospital, London, United KingdomFaculty of Health and Applied Sciences, University of the West of England, Bristol, United KingdomDepartment of Endocrinology, King's College Hospital, London, United KingdomDepartment of Haematological Medicine, King's Thrombosis Centre, King's College Hospital, London, United KingdomAbstract Introduction Increased visceral adipose tissue (VAT) has been shown to be associated with the development of insulin resistance, type 2 diabetes, stroke, and ischemic heart disease. It remains unknown whether fat distribution impacts on coagulation markers and/or the risk of venous thrombosis. This study evaluates markers of hypercoagulability in class III obesity (body mass index [BMI] >40 kg/m2) compared with nonobese controls. We further investigated whether hypercoagulability was influenced by VAT, metabolic syndrome, and metabolic markers, including adiponectin. Patients and Methods Ninety patients were recruited from the obesity clinic at King's College Hospital from November 2009 to December 2011. The inclusion criteria were class III obesity (BMI ≥40 kg/m2) and age 18 to 65 years. A control group (healthy ambulatory participants, with a BMI < 30 kg/m2) was recruited from volunteers responding to advertisement. Abdominal VAT and subcutaneous adipose tissue surface areas were determined by evaluation of a single-slice CT at spinal vertebra L4. Results Thrombin generation revealed a significantly increased peak and endogenous thrombin potential in patients compared with controls. Lag time and time to peak (ttP) were also significantly prolonged in patients. VAT was found to have the strongest association with thrombin generation parameters: lag time (β = 0.378; p < 0.001), peak thrombin (0.378; p = 0.04), and ttP (β = 0.373; p = 0.001). BMI was found to be a predictor for lag time only (β = 0.313; p = 0.003). SAT was not associated with any of the thrombin generation parameters (data not shown). VAT was found to be an independent determinant of peak thrombin, lag time, and ttP. The study suggests not only fat mass but also fat distribution, particularly visceral adiposity, mediates hypercoagulability in obesity.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608942coagulation factorsvisceral adipose tissuehemostatic markertissue factor pathway inhibitorvenous thrombosis
spellingShingle P. B. Chitongo
L. N. Roberts
L. Yang
R. K. Patel
R. Lyall
R. Luxton
S. J. B. Aylwin
R. Arya
Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity
TH Open
coagulation factors
visceral adipose tissue
hemostatic marker
tissue factor pathway inhibitor
venous thrombosis
title Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity
title_full Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity
title_fullStr Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity
title_full_unstemmed Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity
title_short Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity
title_sort visceral adiposity is an independent determinant of hypercoagulability as measured by thrombin generation in morbid obesity
topic coagulation factors
visceral adipose tissue
hemostatic marker
tissue factor pathway inhibitor
venous thrombosis
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0037-1608942
work_keys_str_mv AT pbchitongo visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT lnroberts visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT lyang visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT rkpatel visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT rlyall visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT rluxton visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT sjbaylwin visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity
AT rarya visceraladiposityisanindependentdeterminantofhypercoagulabilityasmeasuredbythrombingenerationinmorbidobesity